Workshop A: Controlling Exposure to New Drug Modalities – ADCs, Cell & Gene Therapies & Radiopharmaceuticals
9:00 am - Tuesday 16th March 2027
Master the technical challenges of safely handling next generation therapeutics including antibody-drug conjugates
(ADCs), cell and gene therapies, and radiopharmaceuticals like Actinium-225.
This deep-dive workshop covers occupational exposure banding (OEB) methodologies, quantitative exposure assessment techniques, and engineering control strategies for high-potency compounds. Learn how to evaluate containment solutions, select appropriate equipment vendors within budget constraints, and implement closed-system handling for alpha emitters and other high-risk isotopes. Walk away with risk assessment frameworks, exposure control hierarchies, and vendor evaluation criteria specifically tailored to emerging biopharma modalities.
